Toll-like receptor 4 in inflammation and angiogenesis: A double-edged sword

Frontiers in Immunology

Volumn 5, Issue JUL, 2014, Pages

  Murad, Sheeba ^a  

^a NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

Angiogenesis; DAMPs; LPS; PAMPS; TLR4

Indexed keywords

EID: 84905665143     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00313     Document Type: Note

References (48)

1. Taguchi T, Mitcham JL, Dower SK, Sims JE, Testa JR. Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14. Genomics (1996) 32:486-8. doi: 10.1006/geno.1996.0150
2. Fehlbaum P, Bulet P, Michaut L, Lagueux M, Broeckaert W, Hetru C, et al. Insect immunity: septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides. J Biol Chem (1994) 269:33159-33163.
3. Medzhitov R, Preston-Hurlburt P, Janeway C. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 388:394-397. doi:10.1038/41131
4. Pichlmair A, Reise Sousa C. Innate recognition of viruses. Immunity (2007) 27:370-83. doi:10.1016/j.immuni.2007.08.012
5. Brikos C, O'Neill LA. Signalling of Toll-like receptors. Handb Exp Pharmacol (2008) 183:21-50. doi:10.1007/978-3-540-72167-3_2
6. Yu L, Wang L, Chen S. Endogenous Toll-like receptor ligands and their biological significance. J Cell Mol (2010) 14:2592-603. doi:10.1111/j.1582-4934.2010.01127.x
7. Kang S, Lee SP, Kim KE, Kim HZ, Mémet S, Koh GY. Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotatic recruitment of macrophages. Blood (2009) 113(11):2605-13. doi:10.1182/blood-2008-07-166934
8. Andonegui G, Bonder CS, Green F, Mullaly SC, Zbytnuik L, Raharjo E, et al. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest (2003) 111:1011-20. doi:10.1172/JCI16510
9. Zhou H, Lapointe BM, Clark SR, Zbytnuik L, Kubes P. A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J Immunol (2006) 177(11):8103-10. doi:10.4049/jimmunol.177.11.8103
10. Satoh M, Ishikawa Y, Minami Y, Takahashi Y, Nakamura M. Role of Toll like receptor signaling pathway in ischemic coronary artery disease. Front Biosci (2008) 13:6708-15. doi:10.2741/3183
11. Ehsan N, Murad S, Ashiq T, Mansoor MU, Gul S, Khalid S, et al. Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast. Tumour Biol (2013) 34(2):1053-9. doi:10.1007/s13277-013-0645-y
12. Frantz S, Ertl G, Bauersachs J. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med (2007) 4:444-54. doi:10.1038/ncpcardio0938
13. Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res (2007) 100(2):158-73. doi:10.1161/01.RES.0000255691.76142.4a
14. Carmeliet P. Angiogenesis in life, disease and medicine. Nature (2005) 438:932-6. doi:10.1038/nature04478
15. Sato TN. Vascular development: molecular logic for defining arteries and veins. Curr Opin Hematol (2003) 10:131-5. doi:10.1097/00062752-200303000-00006
16. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature (2000) 407:242-8. doi:10.1038/35025215
17. Dvoriantchikova G, Barakat DJ, Hernandez E, Shestopalov VI, Ivanova D. Liposome-delivered ATP effectively protects the retina against ischemia-reperfusion injury. Mol Vis (2010) 16:2882-90.
18. Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, Boons GJ, et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol (2003) 163(2):711-21. doi:10.1016/S0002-9440(10)63698-X
19. Wu WK, Llewellyn OP, Bates DO, Nicholson LB, Dick AD. IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia. Immunobiology (2010) 215(9-10):796-803. doi:10.1016/j.imbio.2010.05.025
20. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem (1994) 269:6271-4.
21. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem (1995) 270:13333-40. doi:10.1074/jbc.270.22.13333
22. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem (1996) 271:736-741. doi:10.1074/jbc.271.2.736
23. Gille J, Swerlick RA, Caughman SW. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J (1997) 16:750-759. doi:10.1093/emboj/16.4.750
24. Xiong M, Elson G, Legarda D, Leibovich SJ. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol (1998) 153:587-98. doi:10.1016/S0002-9440(10)65601-5
25. Leibovich SJ, Chen JF, Pinhal-Enfield G, Belem PC, Elson G, Rosania A, et al. Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. Am J Pathol (2002) 160(6):2231-44. doi:10.1016/S0002-9440(10)61170-4
26. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, et al. Nomenclature and classification of purinoreceptors. Pharmacol Rev (1994) 46:143-56.
27. Ramanathan M, Pinhal-Enfield G, Hao I, Leibovich SJ. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter. Mol Biol Cell (2007) 18:14-23. doi:10.1091/mbc.E06-07-0596
28. Fan J, Frey RS, Malik AB. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J Clin Invest (2003) 112:1234-43. doi:10.1172/JCI200318696
29. Li X, Tupper JC, Bannerman DD, Winn RK, Rhodes CJ, Harlan JM. Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infect Immun (2003) 71(8):4414-20. doi:10.1128/IAI.71.8.4414-4420.2003
30. Lloyd K, Kubes P. GPI-linked endothelial CD14 contributes to the detection of LPS. Am J Physiol Heart Circ Physiol (2006) 291(1):H473. doi:10.1152/ajpheart.01234.2005
31. Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, et al. Bacterial lipopolysaccharide activates NF-kappaB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem (2000) 275(15):11058-63. doi:10.1074/jbc.275.15.11058
32. Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, et al. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem (1999) 274(12):7611-4. doi:10.1074/jbc.274.12.7611
33. Ling Y, Wang L, Chen Y, Feng F, You Q, Lu N, et al. Baicalein inhibits angiogenesis induced by lipopolysaccharide through TRAF6 mediated Toll-like receptor 4 pathway. Biomed Prev Nutr (2011) 1:172-9. doi:10.1016/j.bionut.2011.06.013
34. Harmey JH, Bucana CD, Lu W, Byrne AM, McDonnell S, Lynch C, et al. Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer (2002) 101:415-22. doi:10.1002/ijc.10632
35. Wu CX, Sun H, Liu Q, Guo H, Gong JP. LPS induces HMGB1 relocation and release by activating the NF-kB-CBP. Signal transduction pathway in the murine macrophage-like cell line RAW264.7. J Surg Res (2012) 175(1):88-100. doi:10.1016/j.jss.2011.02.026
36. He C, Sun Y, Ren X, Lin Q, Hu X, Huang X, et al. Angiogenesis mediated by Toll-like receptor 4 in ischemic neural tissue. Arterioscler Thromb Vasc Biol (2013) 33(2):330-8. doi:10.1161/ATVBAHA.112.300679
37. Van Beijnum JR, Nowak-Sliwinska P, van den Boezem E, Hautvast P, Buurman WA, Griffioen AW. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene (2013) 32(3):363-74. doi:10.1038/onc.2012.49
38. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol (2000) 190(3):255-66. doi:10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6
39. Hori M, Nishida K. Toll-like receptor signaling defensive or offensive for the heart? Circ Res (2008) 102:137-9. doi:10.1161/CIRCRESAHA.107.170225
40. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA, et al. Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice. Circulation (2004) 109(6):784-9. doi:10.1161/01.CIR.0000112575.66565.84
41. Cao CX, Yang QW, Lv FL, Cui J, Fu HB, Wang JZ. Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem Biophys Res Commun (2007) 353(2):509-14. doi:10.1016/j.bbrc.2006.12.057
42. Tatum PM Jr, Harmon CM, Lorenz RG, Dimmitt RA. Toll-like receptor 4 is protective against neonatal murine ischemia-reperfusion intestinal injury. J Pediatr Surg (2010) 45(6):1246-55. doi:10.1016/j.jpedsurg.2010.02.093
43. Ellett JD, Evans ZP, Atkinson C, Schmidt MG, Schnellmann RG, Chavin KD. Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury. Liver Transpl (2009) 15(9):1101-9. doi:10.1002/lt.21782
44. Ungaro R, Fukata M, Hsu D, Hernandez Y, Breglio K, Chen A, et al. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol (2009) 296:G1167-79. doi:10.1152/ajpgi.90496.2008
45. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation (2002) 105(10):1158-61.
46. Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax (2007) 62:211-8. doi:10.1136/thx.2006.061358
47. Chen Y, Lu N, Ling Y, Gao Y, Wang L, Sun Y, et al. Wogonoside inhibits lipopolysaccharide-induced angiogenesis in vitro and in vivo via Toll-like receptor 4 signal transduction. Toxicology (2009) 259(1-2):10-7. doi:10.1016/j.tox.2009.01.010
48. Ni H, Zhao W, Kong X, Li H, Ouyang J. Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation. Acta Haematol (2014) 131(2):102-11. doi:10.1159/000354770